• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解哮喘患者在乙酰甲胆碱激发试验期间如何感知症状困扰。

Understanding how asthmatics perceive symptom distress during a methacholine challenge.

作者信息

Hardie Grace E, Gold Warren M, Janson Susan, Carrieri-Kohlman Virginia, Boushey Homer A

机构信息

Department of Nursing, The University of California at San Francisco, USA.

出版信息

J Asthma. 2002 Oct;39(7):611-8. doi: 10.1081/jas-120014925.

DOI:10.1081/jas-120014925
PMID:12442950
Abstract

The way, or ways, in which asthmatics recognize specific symptom(s) with varying degrees of their airway obstruction, or asthma severity, is poorly understood. Our purpose was to gain a better understanding of how asthma patients during acute episodes, based on their symptom perception, decide when to seek symptom relief. A cross-sectional design was used to study 32, 16 per group, African Americans and Caucasians with a mean age of 34.5 years. All had mild, stable asthma (FEV1 > or = 70%), were non-smokers, atopic, and had not used inhaled or oral steroids for 3 months. Their mean baseline FEV1 was 97.5% predicted; all were controlled with intermittent use of a beta agonist inhaler. All had a bronchoconstrictor challenge using a provocative concentration of methacholine to achieve a 30% fall (PC30) in their FEV1. After achieving a PC30 and before their first dose of a bronchodilator was given, all subjects were asked: "If you felt this way at home would you take your inhaler?" Subjects were blinded to the fact that the yes/no question was asked when their FEV1 was reduced by 30%. In both groups, 44% responded "no" that they would not use their inhaler at that point in time. This finding suggests that those subjects, the 44% who failed to associate a change in their symptoms with increased airflow obstruction, may be at risk for life-threatening episodes.

摘要

哮喘患者识别特定症状与不同程度气道阻塞或哮喘严重程度之间的方式,目前了解甚少。我们的目的是更好地了解哮喘患者在急性发作期间,基于其症状感知,如何决定何时寻求症状缓解。采用横断面设计研究了32名患者,每组16名,为非裔美国人和白种人,平均年龄34.5岁。所有患者均患有轻度、稳定型哮喘(FEV1≥70%),不吸烟,有特应性,且3个月内未使用吸入或口服类固醇。他们的平均基线FEV1为预测值的97.5%;所有患者通过间歇性使用β受体激动剂吸入器得到控制。所有患者均使用激发浓度的乙酰甲胆碱进行支气管收缩激发试验,以使FEV1下降30%(PC30)。在达到PC30后且在给予第一剂支气管扩张剂之前,所有受试者被问及:“如果你在家有这种感觉,会使用吸入器吗?”受试者对在FEV1下降30%时被问及是/否问题这一事实不知情。在两组中,44%的受试者回答“不会”,即在那个时间点不会使用吸入器。这一发现表明,那些未能将症状变化与气流阻塞增加联系起来的受试者,即44%的受试者,可能面临危及生命发作的风险。

相似文献

1
Understanding how asthmatics perceive symptom distress during a methacholine challenge.了解哮喘患者在乙酰甲胆碱激发试验期间如何感知症状困扰。
J Asthma. 2002 Oct;39(7):611-8. doi: 10.1081/jas-120014925.
2
Perception of methacholine-induced airway obstruction in asthmatics.哮喘患者对乙酰甲胆碱诱发气道阻塞的感知
Monaldi Arch Chest Dis. 2000 Oct;55(5):365-70.
3
Perception of dyspnea in mild smoking asthmatics.轻度吸烟哮喘患者的呼吸困难感知
Respir Med. 2007 Jul;101(7):1426-30. doi: 10.1016/j.rmed.2007.01.019. Epub 2007 Mar 13.
4
The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.甘罗溴铵和茚达特罗单用和联用对轻度哮喘患者乙酰甲胆碱剂量-反应曲线的影响:一项随机三交叉研究。
Respir Res. 2017 Aug 2;18(1):146. doi: 10.1186/s12931-017-0628-4.
5
Adrenergic responsiveness: FEV1 and symptom differences in Whites and African Americans with mild asthma.肾上腺素能反应性:轻度哮喘白人和非裔美国人的第一秒用力呼气量及症状差异
J Asthma. 2007 Oct;44(8):621-8. doi: 10.1080/02770900701540481.
6
Airway responsiveness as a direct factor contributing to the dyspnoea perception in asthma.气道反应性是导致哮喘患者呼吸困难感知的直接因素。
Respir Med. 2001 Jun;95(6):464-70. doi: 10.1053/rmed.2001.1068.
7
Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.长效和短效β受体激动剂对哮喘患者乙酰甲胆碱剂量反应曲线的影响。
Eur Respir J. 1997 Feb;10(2):330-6. doi: 10.1183/09031936.97.10020330.
8
Methacholine-induced fall in forced vital capacity as a marker of asthma severity.作为哮喘严重程度指标的乙酰甲胆碱诱发的用力肺活量下降
Respir Med. 1999 Apr;93(4):277-82. doi: 10.1016/s0954-6111(99)90025-2.
9
Acute bronchial obstruction following inhalation of PAF in asthmatic and normal subjects: comparison with methacholine.哮喘患者和正常受试者吸入血小板活化因子后急性支气管阻塞:与乙酰甲胆碱的比较。
Eur Respir J. 1996 Jul;9(7):1414-20. doi: 10.1183/09031936.96.09071414.
10
Dependence of bronchoconstrictor and bronchodilator responses on thoracic gas compression volume.支气管收缩和舒张反应对胸腔气体压缩量的依赖性。
Respirology. 2014 Oct;19(7):1040-5. doi: 10.1111/resp.12349. Epub 2014 Jul 14.

引用本文的文献

1
Factors associated with discrepancies between poor dyspnea perception and abnormal lung function in 65 asthmatic patients.65 例哮喘患者中呼吸困难感知不良与肺功能异常之间差异的相关因素。
Afr Health Sci. 2020 Sep;20(3):1471-1477. doi: 10.4314/ahs.v20i3.53.
2
Can EVH Results Predict Post-Exercise Changes in FEV Following Interval and Continuous Exercise?EVH 结果能否预测间歇和连续运动后 FEV 的运动后变化?
Lung. 2019 Oct;197(5):609-612. doi: 10.1007/s00408-019-00264-x. Epub 2019 Sep 4.
3
Differing reports of asthma symptoms in African Americans and Caucasians.
非裔美国人和高加索人哮喘症状的不同报告。
J Asthma. 2008 Mar;45(2):165-70. doi: 10.1080/02770900701847076.